Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ehmann

Showing results (601-610 of 645) with videos related to

Pageof 65
Sort By:
Gastroenterology|April 7, 2020
Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated DysbiosisGeethanjali Pickert, Stefan Wirtz, Johannes Matzner, et al.
Journal of Medicinal Chemistry|October 18, 2011
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activityFolkert Reck, Richard Alm, Patrick Brassil, et al.
Molecular and Cellular Biology|November 1, 2021
The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized PatientsMegan McAleavy, Qian Zhang, Peter J Ehmann, et al.
Neuropsychiatric Disease and Treatment|December 22, 2017
Verbal memory improvement in first-episode psychosis <i>APOE</i>-ε4 carriers: a pleiotropic effect?Fidel Vila-Rodriguez, Donna J Lang, Heather Baitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemiaEric J Feldman, Joseph Brandwein, Richard Stone, et al.
Artificial Intelligence in Medicine|March 29, 2024
Multicentric development and validation of a multi-scale and multi-task deep learning model for comprehensive lower extremity alignment analysisNikolas J Wilhelm, Claudio E von Schacky, Felix J Lindner, et al.
British Journal of Haematology|March 13, 2016
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402Michael E Williams, Fangxin Hong, Randy D Gascoyne, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 13, 2018
Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic ApplicationChuan Shen, Andrea Iskenderian, Dianna Lundberg, et al.
Radiation Oncology (London, England)|May 29, 2026
HyperSight<sup>TM</sup>-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility studyVictor Siefert, Joana V Bettenhausen, Alicia S Bicu, et al.
Gut|March 8, 2013
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatmentCornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, et al.
Pageof 65

Showing results (601-610 of 645) with videos related to

Sort By:
Pageof 65
Gastroenterology|April 7, 2020
Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated DysbiosisGeethanjali Pickert, Stefan Wirtz, Johannes Matzner, et al.
Journal of Medicinal Chemistry|October 18, 2011
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activityFolkert Reck, Richard Alm, Patrick Brassil, et al.
Molecular and Cellular Biology|November 1, 2021
The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized PatientsMegan McAleavy, Qian Zhang, Peter J Ehmann, et al.
Neuropsychiatric Disease and Treatment|December 22, 2017
Verbal memory improvement in first-episode psychosis <i>APOE</i>-ε4 carriers: a pleiotropic effect?Fidel Vila-Rodriguez, Donna J Lang, Heather Baitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemiaEric J Feldman, Joseph Brandwein, Richard Stone, et al.
Artificial Intelligence in Medicine|March 29, 2024
Multicentric development and validation of a multi-scale and multi-task deep learning model for comprehensive lower extremity alignment analysisNikolas J Wilhelm, Claudio E von Schacky, Felix J Lindner, et al.
British Journal of Haematology|March 13, 2016
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402Michael E Williams, Fangxin Hong, Randy D Gascoyne, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 13, 2018
Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic ApplicationChuan Shen, Andrea Iskenderian, Dianna Lundberg, et al.
Radiation Oncology (London, England)|May 29, 2026
HyperSight<sup>TM</sup>-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility studyVictor Siefert, Joana V Bettenhausen, Alicia S Bicu, et al.
Gut|March 8, 2013
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatmentCornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, et al.
Pageof 65